학술논문

A large-scale drug screen identifies selective inhibitors of class i HDACs as a potential therapeutic option for SHH medulloblastoma
Document Type
Article
Source
In: Neuro-Oncology. (Neuro-Oncology, 6 September 2019, 21(9):1150-1163)
Subject
Language
English
ISSN
15235866
15228517